EMEA (Europe, Middle East and Africa) Hemostatic Agents Market Report 2017

October 2017 | 126 pages | ID: ED142B284A8EN
QYResearch

Abstracts

In this report, the EMEA Hemostatic Agents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Hemostatic Agents for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Hemostatic Agents market competition by top manufacturers/players, with Hemostatic Agents sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Baxter International Incorporation
• C.R. Bard Incorporation
• B.Braun Melsungen AG
• Integra Life Sciences Corporation
• Equimedical
• Marine Polymer Technologies
• Gelita GmbH
• Pfizer Inc
• Advanced Medical Solutions Group
• Vascular Solutions, Inc
• Z-Medica LLC
• Mallinckrodt Plc
• Covidien PLC.
• Atrium Medical Corporation
• Sanofi Group
• Cryolife, Inc.
• Hemostasis, LLC
• Ethicon
• The Medicines Company
• Anika Therapeutics
• Biom'Up SAS
• BioCer Entwicklungs

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

• Oxidized Regenerated Cellulose
• Combination
• Gelatin
• Thrombin
• Collagen
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Hemostatic Agents for each application, including

• Hospitals
• Surgical Centers
• Nursing Homes
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Hemostatic Agents Market Report 2017

1 HEMOSTATIC AGENTS OVERVIEW

1.1 Product Overview and Scope of Hemostatic Agents
1.2 Classification of Hemostatic Agents
  1.2.1 EMEA Hemostatic Agents Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Hemostatic Agents Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oxidized Regenerated Cellulose
  1.2.4 Combination
  1.2.5 Gelatin
  1.2.6 Thrombin
  1.2.7 Collagen
  1.2.8 Other
1.3 EMEA Hemostatic Agents Market by Application/End Users
  1.3.1 EMEA Hemostatic Agents Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospitals
  1.3.3 Surgical Centers
  1.3.4 Nursing Homes
  1.3.5 Others
1.4 EMEA Hemostatic Agents Market by Region
  1.4.1 EMEA Hemostatic Agents Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Hemostatic Agents (2012-2022)
  1.5.1 EMEA Hemostatic Agents Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Hemostatic Agents Revenue and Growth Rate (2012-2022)

2 EMEA HEMOSTATIC AGENTS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Hemostatic Agents Market Competition by Players/Manufacturers
  2.1.1 EMEA Hemostatic Agents Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Hemostatic Agents Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Hemostatic Agents Sale Price by Players (2012-2017)
2.2 EMEA Hemostatic Agents (Volume and Value) by Type/Product Category
  2.2.1 EMEA Hemostatic Agents Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Hemostatic Agents Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Hemostatic Agents Sale Price by Type (2012-2017)
2.3 EMEA Hemostatic Agents (Volume) by Application
2.4 EMEA Hemostatic Agents (Volume and Value) by Region
  2.4.1 EMEA Hemostatic Agents Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Hemostatic Agents Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Hemostatic Agents Sales Price by Region (2012-2017)

3 EUROPE HEMOSTATIC AGENTS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Hemostatic Agents Sales and Value (2012-2017)
  3.1.1 Europe Hemostatic Agents Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Hemostatic Agents Revenue and Growth Rate (2012-2017)
3.2 Europe Hemostatic Agents Sales and Market Share by Type
3.3 Europe Hemostatic Agents Sales and Market Share by Application
3.4 Europe Hemostatic Agents Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Hemostatic Agents Sales Volume by Countries (2012-2017)
  3.4.2 Europe Hemostatic Agents Revenue by Countries (2012-2017)
  3.4.3 Germany Hemostatic Agents Sales and Growth Rate (2012-2017)
  3.4.4 France Hemostatic Agents Sales and Growth Rate (2012-2017)
  3.4.5 UK Hemostatic Agents Sales and Growth Rate (2012-2017)
  3.4.6 Russia Hemostatic Agents Sales and Growth Rate (2012-2017)
  3.4.7 Italy Hemostatic Agents Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Hemostatic Agents Sales and Growth Rate (2012-2017)

4 MIDDLE EAST HEMOSTATIC AGENTS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Hemostatic Agents Sales and Value (2012-2017)
  4.1.1 Middle East Hemostatic Agents Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Hemostatic Agents Revenue and Growth Rate (2012-2017)
4.2 Middle East Hemostatic Agents Sales and Market Share by Type
4.3 Middle East Hemostatic Agents Sales and Market Share by Application
4.4 Middle East Hemostatic Agents Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Hemostatic Agents Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Hemostatic Agents Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Hemostatic Agents Sales and Growth Rate (2012-2017)
  4.4.4 Israel Hemostatic Agents Sales and Growth Rate (2012-2017)
  4.4.5 UAE Hemostatic Agents Sales and Growth Rate (2012-2017)
  4.4.6 Iran Hemostatic Agents Sales and Growth Rate (2012-2017)

5 AFRICA HEMOSTATIC AGENTS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Hemostatic Agents Sales and Value (2012-2017)
  5.1.1 Africa Hemostatic Agents Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Hemostatic Agents Revenue and Growth Rate (2012-2017)
5.2 Africa Hemostatic Agents Sales and Market Share by Type
5.3 Africa Hemostatic Agents Sales and Market Share by Application
5.4 Africa Hemostatic Agents Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Hemostatic Agents Sales Volume by Countries (2012-2017)
  5.4.2 Africa Hemostatic Agents Revenue by Countries (2012-2017)
  5.4.3 South Africa Hemostatic Agents Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Hemostatic Agents Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Hemostatic Agents Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Hemostatic Agents Sales and Growth Rate (2012-2017)

6 EMEA HEMOSTATIC AGENTS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Baxter International Incorporation
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hemostatic Agents Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter International Incorporation Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 C.R. Bard Incorporation
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Hemostatic Agents Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 C.R. Bard Incorporation Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 B.Braun Melsungen AG
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Hemostatic Agents Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 B.Braun Melsungen AG Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Integra Life Sciences Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Hemostatic Agents Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Integra Life Sciences Corporation Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Equimedical
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Hemostatic Agents Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Equimedical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Marine Polymer Technologies
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Hemostatic Agents Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Gelita GmbH
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Hemostatic Agents Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Gelita GmbH Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Pfizer Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Hemostatic Agents Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Pfizer Inc Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Advanced Medical Solutions Group
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Hemostatic Agents Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Advanced Medical Solutions Group Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Vascular Solutions, Inc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Hemostatic Agents Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Vascular Solutions, Inc Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Z-Medica LLC
6.12 Mallinckrodt Plc
6.13 Covidien PLC.
6.14 Atrium Medical Corporation
6.15 Sanofi Group
6.16 Cryolife, Inc.
6.17 Hemostasis, LLC
6.18 Ethicon
6.19 The Medicines Company
6.20 Anika Therapeutics
6.21 Biom'Up SAS
6.22 BioCer Entwicklungs

7 HEMOSTATIC AGENTS MANUFACTURING COST ANALYSIS

7.1 Hemostatic Agents Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hemostatic Agents

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hemostatic Agents Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hemostatic Agents Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HEMOSTATIC AGENTS MARKET FORECAST (2017-2022)

11.1 EMEA Hemostatic Agents Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Hemostatic Agents Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Hemostatic Agents Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Hemostatic Agents Price and Trend Forecast (2017-2022)
11.2 EMEA Hemostatic Agents Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Hemostatic Agents Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Hemostatic Agents Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Hemostatic Agents Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Hemostatic Agents Sales Forecast by Type (2017-2022)
11.7 EMEA Hemostatic Agents Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Hemostatic Agents
Figure EMEA Hemostatic Agents Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Hemostatic Agents Sales Volume Market Share by Type (Product Category) in 2016
Figure Oxidized Regenerated Cellulose Product Picture
Figure Combination Product Picture
Figure Gelatin Product Picture
Figure Thrombin Product Picture
Figure Collagen Product Picture
Figure Other Product Picture
Figure EMEA Hemostatic Agents Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Hemostatic Agents by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Surgical Centers Examples
Table Key Downstream Customer in Surgical Centers
Figure Nursing Homes Examples
Table Key Downstream Customer in Nursing Homes
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Hemostatic Agents Market Size (Million USD) by Region (2012-2022)
Figure Europe Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hemostatic Agents Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Hemostatic Agents Revenue (Million USD) Status and Forecast by Countries
Figure Africa Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Hemostatic Agents Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Hemostatic Agents Sales Volume and Growth Rate (2012-2022)
Figure EMEA Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Hemostatic Agents Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Hemostatic Agents Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Hemostatic Agents Sales Share by Players (2012-2017)
Figure 2016 Hemostatic Agents Sales Share by Players
Figure 2017 Hemostatic Agents Sales Share by Players
Figure EMEA Hemostatic Agents Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Hemostatic Agents Revenue (Million USD) by Players (2012-2017)
Table EMEA Hemostatic Agents Revenue Share by Players (2012-2017)
Table 2016 EMEA Hemostatic Agents Revenue Share by Players
Table 2017 EMEA Hemostatic Agents Revenue Share by Players
Table EMEA Hemostatic Agents Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Hemostatic Agents Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Hemostatic Agents Sales Share by Type (2012-2017)
Figure Sales Market Share of Hemostatic Agents by Type (2012-2017)
Figure EMEA Hemostatic Agents Sales Market Share by Type (2012-2017)
Table EMEA Hemostatic Agents Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Hemostatic Agents Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hemostatic Agents by Type in 2016
Table EMEA Hemostatic Agents Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Hemostatic Agents Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Hemostatic Agents Sales Share by Application (2012-2017)
Figure Sales Market Share of Hemostatic Agents by Application (2012-2017)
Figure EMEA Hemostatic Agents Sales Market Share by Application in 2016
Table EMEA Hemostatic Agents Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Hemostatic Agents Sales Share by Region (2012-2017)
Figure Sales Market Share of Hemostatic Agents by Region (2012-2017)
Figure EMEA Hemostatic Agents Sales Market Share in 2016
Table EMEA Hemostatic Agents Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Hemostatic Agents Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Hemostatic Agents by Region (2012-2017)
Figure EMEA Hemostatic Agents Revenue Market Share Regions in 2016
Table EMEA Hemostatic Agents Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Hemostatic Agents Revenue and Growth Rate (2012-2017)
Table Europe Hemostatic Agents Sales (K MT) by Type (2012-2017)
Table Europe Hemostatic Agents Market Share by Type (2012-2017)
Figure Europe Hemostatic Agents Market Share by Type in 2016
Table Europe Hemostatic Agents Sales (K MT) by Application (2012-2017)
Table Europe Hemostatic Agents Market Share by Application (2012-2017)
Figure Europe Hemostatic Agents Market Share by Application in 2016
Table Europe Hemostatic Agents Sales (K MT) by Countries (2012-2017)
Table Europe Hemostatic Agents Sales Market Share by Countries (2012-2017)
Figure Europe Hemostatic Agents Sales Market Share by Countries (2012-2017)
Figure Europe Hemostatic Agents Sales Market Share by Countries in 2016
Table Europe Hemostatic Agents Revenue (Million USD) by Countries (2012-2017)
Table Europe Hemostatic Agents Revenue Market Share by Countries (2012-2017)
Figure Europe Hemostatic Agents Revenue Market Share by Countries (2012-2017)
Figure Europe Hemostatic Agents Revenue Market Share by Countries in 2016
Figure Germany Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure France Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure UK Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Hemostatic Agents Sales (K MT) by Type (2012-2017)
Table Middle East Hemostatic Agents Market Share by Type (2012-2017)
Figure Middle East Hemostatic Agents Market Share by Type (2012-2017)
Table Middle East Hemostatic Agents Sales (K MT) by Applications (2012-2017)
Table Middle East Hemostatic Agents Market Share by Applications (2012-2017)
Figure Middle East Hemostatic Agents Sales Market Share by Application in 2016
Table Middle East Hemostatic Agents Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Hemostatic Agents Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Hemostatic Agents Sales Volume Market Share by Countries in 2016
Table Middle East Hemostatic Agents Revenue (Million USD) by Countries (2012-2017)
Table Middle East Hemostatic Agents Revenue Market Share by Countries (2012-2017)
Figure Middle East Hemostatic Agents Revenue Market Share by Countries (2012-2017)
Figure Middle East Hemostatic Agents Revenue Market Share by Countries in 2016
Figure Saudi Arabia Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Hemostatic Agents Sales (K MT) by Type (2012-2017)
Table Africa Hemostatic Agents Sales Market Share by Type (2012-2017)
Figure Africa Hemostatic Agents Sales Market Share by Type (2012-2017)
Figure Africa Hemostatic Agents Sales Market Share by Type in 2016
Table Africa Hemostatic Agents Sales (K MT) by Application (2012-2017)
Table Africa Hemostatic Agents Sales Market Share by Application (2012-2017)
Figure Africa Hemostatic Agents Sales Market Share by Application (2012-2017)
Table Africa Hemostatic Agents Sales Volume (K MT) by Countries (2012-2017)
Table Africa Hemostatic Agents Sales Market Share by Countries (2012-2017)
Figure Africa Hemostatic Agents Sales Market Share by Countries (2012-2017)
Figure Africa Hemostatic Agents Sales Market Share by Countries in 2016
Table Africa Hemostatic Agents Revenue (Million USD) by Countries (2012-2017)
Table Africa Hemostatic Agents Revenue Market Share by Countries (2012-2017)
Figure Africa Hemostatic Agents Revenue Market Share by Countries (2012-2017)
Figure Africa Hemostatic Agents Revenue Market Share by Countries in 2016
Figure South Africa Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Table Baxter International Incorporation Hemostatic Agents Basic Information List
Table Baxter International Incorporation Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Baxter International Incorporation Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Baxter International Incorporation Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure Baxter International Incorporation Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table C.R. Bard Incorporation Hemostatic Agents Basic Information List
Table C.R. Bard Incorporation Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure C.R. Bard Incorporation Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure C.R. Bard Incorporation Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure C.R. Bard Incorporation Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table B.Braun Melsungen AG Hemostatic Agents Basic Information List
Table B.Braun Melsungen AG Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure B.Braun Melsungen AG Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure B.Braun Melsungen AG Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure B.Braun Melsungen AG Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table Integra Life Sciences Corporation Hemostatic Agents Basic Information List
Table Integra Life Sciences Corporation Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Integra Life Sciences Corporation Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Integra Life Sciences Corporation Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure Integra Life Sciences Corporation Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table Equimedical Hemostatic Agents Basic Information List
Table Equimedical Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Equimedical Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Equimedical Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure Equimedical Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table Marine Polymer Technologies Hemostatic Agents Basic Information List
Table Marine Polymer Technologies Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Marine Polymer Technologies Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Marine Polymer Technologies Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure Marine Polymer Technologies Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table Gelita GmbH Hemostatic Agents Basic Information List
Table Gelita GmbH Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Gelita GmbH Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Gelita GmbH Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure Gelita GmbH Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc Hemostatic Agents Basic Information List
Table Pfizer Inc Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Inc Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Inc Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table Advanced Medical Solutions Group Hemostatic Agents Basic Information List
Table Advanced Medical Solutions Group Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Advanced Medical Solutions Group Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Advanced Medical Solutions Group Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure Advanced Medical Solutions Group Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table Vascular Solutions, Inc Hemostatic Agents Basic Information List
Table Vascular Solutions, Inc Hemostatic Agents Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Vascular Solutions, Inc Hemostatic Agents Sales (K MT) and Growth Rate (2012-2017)
Figure Vascular Solutions, Inc Hemostatic Agents Sales Market Share in EMEA (2012-2017)
Figure Vascular Solutions, Inc Hemostatic Agents Revenue Market Share in EMEA (2012-2017)
Table Z-Medica LLC Hemostatic Agents Basic Information List
Table Mallinckrodt Plc Hemostatic Agents Basic Information List
Table Covidien PLC. Hemostatic Agents Basic Information List
Table Atrium Medical Corporation Hemostatic Agents Basic Information List
Table Sanofi Group Hemostatic Agents Basic Information List
Table Cryolife, Inc. Hemostatic Agents Basic Information List
Table Hemostasis, LLC Hemostatic Agents Basic Information List
Table Ethicon Hemostatic Agents Basic Information List
Table The Medicines Company Hemostatic Agents Basic Information List
Table Anika Therapeutics Hemostatic Agents Basic Information List
Table Biom'Up SAS Hemostatic Agents Basic Information List
Table BioCer Entwicklungs Hemostatic Agents Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemostatic Agents
Figure Manufacturing Process Analysis of Hemostatic Agents
Figure Hemostatic Agents Industrial Chain Analysis
Table Raw Materials Sources of Hemostatic Agents Major Manufacturers in 2016
Table Major Buyers of Hemostatic Agents
Table Distributors/Traders List
Figure EMEA Hemostatic Agents Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Hemostatic Agents Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Hemostatic Agents Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Hemostatic Agents Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Hemostatic Agents Sales Market Share Forecast by Region (2017-2022)
Table EMEA Hemostatic Agents Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Hemostatic Agents Revenue Market Share Forecast by Region (2017-2022)
Table Europe Hemostatic Agents Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Hemostatic Agents Sales Market Share Forecast by Countries (2017-2022)
Table Europe Hemostatic Agents Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Hemostatic Agents Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Hemostatic Agents Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Hemostatic Agents Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Hemostatic Agents Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Hemostatic Agents Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Hemostatic Agents Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Hemostatic Agents Sales Market Share Forecast by Countries (2017-2022)
Table Africa Hemostatic Agents Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Hemostatic Agents Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Hemostatic Agents Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Hemostatic Agents Sales Market Share Forecast by Type (2017-2022)
Table EMEA Hemostatic Agents Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Hemostatic Agents Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources